MSD’s Keytruda hits Phase 3 main goal in first-line colorectal cancer sub-population
April 3, 2020Medical Communications, Research and Development MSD, colorectal cancer, keytruda, pharma
MSD has lifted the veil on new Phase 3 for its blockbuster immunotherapy Keytruda, showing that the anti-PD-1 therapy met …
British man charged in the US for smuggling phoney coronavirus cure
April 3, 2020Medical Communications COVID-19, COVID-19 vaccine, Coronavirus Cure, coronavirus
A British man has been accused of smuggling a fake coronavirus cure into the US and has been federally charged. …
Sanofi and Regeneron’s Dupixent combo impresses in paediatric atopic dermatitis
April 3, 2020Medical Communications, Research and Development Dupixent, Sanofi, atopic dermatitis, pharma
Sanofi and Regeneron have unveiled new Phase 3 data for their IL-4 and IL-13 inhibitor Dupixent (dupilumab), showing strong results …
EMA refuses to approve chloroquine for COVID-19 without sufficient data
April 3, 2020Medical Communications COVID-19, chloroquine, coronavirus
The European Medicines Agency has restricted the general use of the drug chloroquine for coronavirus, but allowing its testing in …
FDA calls for heartburn drug Zantac to be pulled due to carcinogen concerns
April 2, 2020Business Services FDA, NDMA, Sanofi, heartburn
The FDA is requesting that manufactures remove Zantac (ranitidine) from the market due to risks of it containing a carcinogen. …
US approval for haemophilia drug derived from genetically engineered rabbit’s milk
April 2, 2020Sales and Marketing FDA, US, haemophilia, pharma
The FDA has announced the approval of Sevenfact, a haemophilia therapy the active ingredient from which is expressed in genetically …
FDA places no penalties on Novartis after Zolgensma data manipulation investigation
April 2, 2020Business Services FDA, Novartis, regulators
The FDA has concluded its investigation into Novartis and its data manipulation of the gene therapy Zolgensma, and has decided …
EUSA Pharma’s COVID-19 drug improves or stabilises respiratory condition in 76% of patients
April 2, 2020Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, siltuximab
EUSA Pharma has unveiled promising preliminary findings from an interim analysis of siltuximab in the treatment of serious respiratory complications …
British American Tobacco creating coronavirus vaccine
April 2, 2020Business Services COVID-19, coronavirus
British American Tobacco has said it is developing a COVID-19 vaccine from tobacco plants. The owner of famous cigarette brands, …
Researchers modify T-cells to identify and target multiple sites on leukaemia cells
April 1, 2020Research and Development Cancer, Cancers, children cancer, leukaemia
Scientists from the Children’s Hospital of Los Angeles have engineered T-cells to identify and target multiple sites on acute lymphoblastic …
The April 2020 issue of Pharmafocus is available to read free online now!
April 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, UK, US, coronavirus, generic medicines, pharma, rare disease, real world data, real-world data
The latest monthly edition of Pharmafocus, the April 2020 issue, is available to read for free online now! There’s one …
FDA aims to accelerate COVID-19 therapies with new programme
April 1, 2020Research and Development COVID-19, FDA, america, coronaviurs
The FDA has launched the Coronavirus Treatment Acceleration Program (CTAP) to quickly bring therapies and treatments to people suffering from …
Europe sells Iran medicine, defying US sanctions
April 1, 2020Research and Development Iran, Iran Sanctions, Iran US, USA, coronavirus
France, Germany and the UK have announced the sale of medicinal goods to Iran, bypassing US sanctions on the country …
Lilly partners with Sitryx in $880m immunometabolism drug development deal
April 1, 2020Research and Development Eli Lilly, Sitryx, partnership, pharma
Eli Lilly and UK firm Sitryx have partnered up in a new drug development and commercialisation deal that could potentially …
Axsome’s late-stage study of experimental depression drug misses main trial goal
March 31, 2020Manufacturing and Production Depressive Disorder, MDD, depression, migraine
Axsome Therapeutics reported on Monday that its Phase 3 study of its experimental depression drug missed its main trial goal. …
Johnson & Johnson selects lead COVID-19 vaccine candidate and targets September Phase I study
March 31, 2020Manufacturing and Production . Johnson & Johnson, Johnson & Johnson, Vaccine, coronavirus, coronavirus vaccine
Johnson & Johnson announced that it has selected a candidate for a COVID-19 vaccine from potential constructs it has been …
Bayer’s Nubeqa combo approved in Europe for non-metastatic castration-resistant prostate cancer
March 31, 2020Manufacturing and Production, Research and Development Bayer, Cancer, Europe, Nubeqa, prostate cancer
The European Commission has given the green light to Bayer’s non-steroidal androgen receptor inhibitor Nubeqa (darolutamide), jointly developed with Orion, …
UK social distancing measures making a difference to the spread of COVID-19, government says
March 31, 2020Manufacturing and Production British Coronavirus, COVID-`9, coronavirus, coronavirus uk
Social distancing measures are slowing down the spread of coronavirus and keeping pressure off the NHS, according to the UK’s …
EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications
March 31, 2020Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma
Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …
People or profit: What is the best system to regulate drug prices?
March 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Conor Kavanagh investigates the role state healthcare institutions play in negotiating drug prices, and what steps can be taken for …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
